February 28, 2022
Paraveganio is now the first medicine in the world to be registered with the Vegan brand, according to the Vegan Society. One of the most widely used painkillers in the world, little is known that paracetamol – and many other drugs – often contain animal derivatives.
Paraveganio hits the market as the world’s first certified vegan paracetamol option, helping to fight fever as well as mild to moderate pain without animal-derived ingredients. Conventional paracetamol tablets contain the rate regulator magnesium stearate – a salt of stearic acid and magnesium which may be of animal origin. Paraveganio’s magnesium stearate is of pure vegetable origin.
Developed by the German pharmaceutical company Axunio, the certified vegan drug contains 500mg of the proven active ingredient paracetamol. While Paraveganio tablets are currently only available in Germany, Axunio plans to expand to other markets. According to the Vegan Society, around 75% of the most commonly prescribed medicines in the UK contain animal products, not to mention animal testing prevalent in the industry.
Make more vegan medicines
Launched in 2017, the Vegan Society’s Make More Medicines Vegan campaign called on the UK government to start using existing animal-free alternatives to prescription products containing animal-derived ingredients, as well as raising awareness among healthcare professionals and the patients. Other companies are currently active in clean medicine, such as French company Veggiepharm and US company Genexa – which raised $60m in Series A funding last year.
“We are excited to see our Vegan brand for the first time on a vegan medicine. We know that many vegans struggle to find medications that both suit their needs and align with their beliefs, which can be a pain. However, axunio has shown how easy it is to create a brilliant vegan product and we can only hope that other pharmaceutical companies will follow suit and work to create more vegan medicines,” commented Ericka Durgahee, Marketing Manager at The Vegan Society.